Research Analysts’ Weekly Ratings Changes for Intellia Therapeutics (NTLA)
Several brokerages have updated their recommendations and price targets on shares of Intellia Therapeutics (NASDAQ: NTLA) in the last few weeks: 5/16/2026 – Intellia Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 5/13/2026 – Intellia Therapeutics had its price target raised by Sanford C. Bernstein from $13.00 to $17.00. They now have […]
19 May 15:40 · The Cerbat Gem